Trained immunity induction by the inactivated mucosal vaccine MV130 protects against experimental viral respiratory infections.
Brandi P, Conejero L, Cueto FJ, Martínez-Cano S, Dunphy G, Gómez MJ, Relaño C, Saz-Leal P, Enamorado M, Quintas A, Dopazo A, Amores-Iniesta J, Del Fresno C, Nistal-Villán E, Ardavín C, Nieto A, Casanovas M, Subiza JL, Sancho D.
Cell Rep. 2022 Jan 4;38(1):110184. doi: 10.1016/j.celrep.2021.110184.
Candidiasis.
Meunier F.
Eur J Clin Microbiol Infect Dis. 1989 May;8(5):438-47. doi: 10.1007/BF01964058.
Candidiasis (oropharyngeal).
Pankhurst CL.
BMJ Clin Evid. 2013 Nov 8;2013:1304.
Candidiasis (oropharyngeal).
Pankhurst CL.
BMJ Clin Evid. 2012 Feb 20;2012:1304.
Candidiasis (oropharyngeal).
Pankhurst CL.
BMJ Clin Evid. 2009 Mar 18;2009:1304.
Laryngeal thrush.
Sulica L.
Ann Otol Rhinol Laryngol. 2005 May;114(5):369-75. doi: 10.1177/000348940511400506.
Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.
de Repentigny L, Lewandowski D, Jolicoeur P.
Clin Microbiol Rev. 2004 Oct;17(4):729-59, table of contents. doi: 10.1128/CMR.17.4.729-759.2004.
Efficacy and safety of oral ciprofloxacin in the treatment of respiratory tract infections associated with chronic hepatitis.
Esposito S, Galante D, Bianchi W, Gagliardi R.
Am J Med. 1987 Apr 27;82(4A):211-4.
The significance of Candida in the human respiratory tract: our evolving understanding.
Pendleton KM, Huffnagle GB, Dickson RP.
Pathog Dis. 2017 Apr 1;75(3):ftx029. doi: 10.1093/femspd/ftx029.
Human Immunodeficiency Virus Infection and Host Defense in the Lungs.
Charles TP, Shellito JE.
Semin Respir Crit Care Med. 2016 Apr;37(2):147-56. doi: 10.1055/s-0036-1572553. Epub 2016 Mar 14.
